INO:NASDAQ
Inovio Pharmaceuticals Inc
1,00 USD
arrow_upward
+1,00%(+0,0099) 1D
1,02 USD
arrow_upward
+2,00% (+0,020)todayPre-market
Closed: 19-окт., 16:00:01 GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for INO...
Open
1,01 USD
High
1,02 USD
Low
0,98 USD
Mkt. cap
103,41 млн
Avg. vol.
2,87 млн
Volume
1,63 миң
52-wk high
2,72 USD
52-wk low
0,57 USD
EPS
-1,17 USD
Beta
1,61
Shares outstanding
103,40 млн
No. of employees
112
Open
1,01 USD
High
1,02 USD
Low
0,98 USD
Mkt. cap
103,41 млн
Avg. vol.
2,87 млн
Volume
1,63 миң
52-wk high
2,72 USD
52-wk low
0,57 USD
EPS
-1,17 USD
Beta
1,61
Shares outstanding
103,40 млн
No. of employees
112
News stories
From web sources and news partners
Simply Wall Street
·
16 мүнөт мурун
Why Is TTM Technologies (TTMI) Buying Ophir Optics For $650 Million?
TradingView
·
1 саат мурун
Asia’s Bitcoin Play Hits Wall Street: Metaplanet Set to Buy This Nasdaq-Listed Company for BTC Treasury Operations
Yahoo Finance
·
33 мүнөт мурун
US Stock Market Today: S&P 500 Futures Climb On Strong Factory And Earnings Hopes
Profile
Inovio Pharmaceuticals, Inc. is an American biotechnology company focused on the discovery, development, and commercialization of synthetic DNA products for treating cancers and infectious diseases. In April 2020, Inovio was among some 100 companies, academic centers, or research organizations developing a vaccine candidate for treating people infected with COVID-19, with more than 170 total vaccine candidates in development. Wikipedia
About Inovio Pharmaceuticals Inc